Familial hypercholesterolemia (FH) is a gene-related metabolic disorder, and it is mainly caused by pathogenic mutations in LDLR, APOB, PCSK9, and LDLRAP1 affecting the LDL receptor (LDLR) pathway [4, 5]. This evidence concerns the gene APOB and familial hyperaldosteronism.